A quantitative trigger model to enable personalized adaptive radiotherapy in nasopharyngeal carcinoma
In brief
An adaptive radiotherapy model matched clinician triggers with AUCs near 0.88
In a retrospective, single-center study of 60 patients with nasopharyngeal cancer, a score combining tumor and organ changes across 1,466 scans flagged when to adapt treatment. In 20 validation patients, agreement with clinician-simulated triggers yielded area-under-the-curve values of 0.872 to 0.879; prospective, multicenter testing is still needed to show how well the model performs in routine care.
- Journal
- Therapeutic advances in medical oncology (Q1)
- Published
- 28 October 2026
- Study design
- Prospective / inception cohort
- Evidence level
- Level 2, Moderate (CEBM 2b)
- Authors
- Xiao-Li Yu, Jiang Hu, Wen-Chao Diao, Guang-Yu Wang, Xin Yang, Lu Liu, et al.
- PMID
- 43048269
- DOI
- 10.1177/17588359261502420
Why clinicians should know about it
- Picked for Medical Physics (paper of the day, 20 November 2026): Quantitative adaptive radiotherapy triggers integrate imaging and dosimetric changes
Abstract
BACKGROUND: Adaptive radiotherapy (ART) is increasingly used for nasopharyngeal carcinoma (NPC), yet optimal triggers remain undefined. OBJECTIVES: This study developed a quantitative trigger model integrating clinical expertise with morphological and dosimetric changes during treatment to support personalized, scalable ART decision-making. DESIGN: This was a single-center, retrospective cohort study conducted at Sun Yat-sen University Cancer Center. METHODS: Between 2022 and 2024, 60 NPC patients treated on an integrated ART platform (uRT-linac 506c) were enrolled. Forty patients who underwent ART at least once during radiotherapy constituted the training set; morphological and dosimetric parameters between the original treatment plan and fractional radiotherapy were quantified, weighted, and modeled using clinician-simulated ART timing as the reference. The remaining 20 patients (17 with ART and 3 without) served as the validation set. RESULTS: A total of 1,466 fan-beam CT scans from 60 patients (40 training, 20 validation) were analyzed. A weighted Trigger Score (TS) was developed, combining volumetric and dosimetric scores in target volumes and key organs-at-risk (parotids, submandibular glands, thyroid, brainstem, spinal cord, optic nerves, chiasm, and temporal lobes). Two trigger modes were defined: 1) an absolute TS ≥65 points, or 2) a TS change ratio ≥1.5 (=TS_y × (y - 2)/Σ TS_2: TS_(y-1), where y = fraction number). In the validation cohort, the model showed high concordance with clinician-simulated triggers, achieving ROC-AUCs of 0.879 (daily) and 0.872 (weekly). The model has been integrated into our clinical ART platform for operational use. CONCLUSION: We developed and validated a transparent, quantitative trigger model integrating clinical expertise with quantified volumetric/dosimetric changes and structural prioritization to enable individualized ART decision-making for NPC. This model supports automated, real-time ART triggering with adjustable thresholds, adaptable to imaging frequencies, and customizable to institutional practice. However, multicenter or prospective validation is still warranted before widespread clinical adoption.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.